{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T06:34:38Z","timestamp":1775889278385,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T00:00:00Z","timestamp":1358380800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.5"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s40264-012-0013-7","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T15:05:54Z","timestamp":1358348754000},"page":"135-144","source":"Crossref","is-referenced-by-count":90,"title":["Transplantation for Acute Liver Failure in Patients Exposed to NSAIDs or Paracetamol (Acetaminophen)"],"prefix":"10.1007","volume":"36","author":[{"given":"Sinem Ezgi","family":"Gulmez","sequence":"first","affiliation":[]},{"given":"Dominique","family":"Larrey","sequence":"additional","affiliation":[]},{"given":"Georges-Philippe","family":"Pageaux","sequence":"additional","affiliation":[]},{"given":"Severine","family":"Lignot","sequence":"additional","affiliation":[]},{"given":"R\u00e9gis","family":"Lassalle","sequence":"additional","affiliation":[]},{"given":"J\u00e9r\u00e9my","family":"Jov\u00e9","sequence":"additional","affiliation":[]},{"given":"Angelo","family":"Gatta","sequence":"additional","affiliation":[]},{"given":"P. Aiden","family":"McCormick","sequence":"additional","affiliation":[]},{"given":"Harold J.","family":"Metselaar","sequence":"additional","affiliation":[]},{"given":"Estela","family":"Monteiro","sequence":"additional","affiliation":[]},{"given":"Douglas","family":"Thorburn","sequence":"additional","affiliation":[]},{"given":"William","family":"Bernal","sequence":"additional","affiliation":[]},{"given":"Irene","family":"Zouboulis-Vafiadis","sequence":"additional","affiliation":[]},{"given":"Corinne","family":"de Vries","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Perez-Gutthann","sequence":"additional","affiliation":[]},{"given":"Miriam","family":"Sturkenboom","sequence":"additional","affiliation":[]},{"given":"Jacques","family":"B\u00e9nichou","sequence":"additional","affiliation":[]},{"given":"Jean-Louis","family":"Montastruc","sequence":"additional","affiliation":[]},{"given":"Yves","family":"Horsmans","sequence":"additional","affiliation":[]},{"given":"Francesco","family":"Salvo","sequence":"additional","affiliation":[]},{"given":"Fatima","family":"Hamoud","sequence":"additional","affiliation":[]},{"given":"Sophie","family":"Micon","sequence":"additional","affiliation":[]},{"given":"C\u00e9cile","family":"Droz-Perroteau","sequence":"additional","affiliation":[]},{"given":"Patrick","family":"Blin","sequence":"additional","affiliation":[]},{"given":"Nicholas","family":"Moore","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,1,17]]},"reference":[{"issue":"6","key":"13_CR1","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/hep.23937","volume":"52","author":"A Reuben","year":"2010","unstructured":"Reuben A, Koch DG, Lee WM, Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology. 2010;52(6):2065\u201376.","journal-title":"Hepatology"},{"key":"13_CR2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/978-3-642-00663-0_13","volume":"196","author":"M Keisu","year":"2010","unstructured":"Keisu M, Andersson TB. Drug-induced liver injury in humans: the case of ximelagatran. Handb Exp Pharmacol. 2010;196:407\u201318.","journal-title":"Handb Exp Pharmacol"},{"issue":"5","key":"13_CR3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMra021844","volume":"349","author":"WM Lee","year":"2003","unstructured":"Lee WM. Drug-induced hepatotoxicity. N Engl J Med. 2003;349(5):474\u201385.","journal-title":"N Engl J Med"},{"issue":"1","key":"13_CR4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0016-5085(85)90765-6","volume":"89","author":"G Danan","year":"1985","unstructured":"Danan G, Trunet P, Bernuau J, Degott C, Babany G, Pessayre D, et al. Pirprofen-induced fulminant hepatitis. Gastroenterology. 1985;89(1):210\u20133.","journal-title":"Gastroenterology"},{"issue":"45","key":"13_CR5","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.3748\/wjg.v16.i45.5651","volume":"16","author":"F Bessone","year":"2010","unstructured":"Bessone F. Non-steroidal anti-inflammatory drugs: what is the actual risk of liver damage? World J Gastroenterol. 2010;16(45):5651\u201361.","journal-title":"World J Gastroenterol"},{"issue":"7405","key":"13_CR6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/bmj.327.7405.18","volume":"327","author":"G Traversa","year":"2003","unstructured":"Traversa G, Bianchi C, Da Cas R, Abraha I, Menniti-Ippolito F, Venegoni M. Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs. BMJ. 2003;327(7405):18\u201322.","journal-title":"BMJ"},{"issue":"7","key":"13_CR7","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/pds.1966","volume":"19","author":"CH Lee","year":"2010","unstructured":"Lee CH, Wang JD, Chen PC. Increased risk of hospitalization for acute hepatitis in patients with previous exposure to NSAIDs. Pharmacoepidemiol Drug Saf. 2010;19(7):708\u201314.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"13_CR8","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/11592140-000000000-00000","volume":"34","author":"H Theophile","year":"2011","unstructured":"Theophile H, Laporte JR, Moore N, Martin KL, Begaud B. The case-population study design: an analysis of its application in pharmacovigilance. Drug Saf. 2011;34(10):861\u20138.","journal-title":"Drug Saf"},{"key":"13_CR9","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/pds.3204","volume":"21","author":"SE Gulmez","year":"2012","unstructured":"Gulmez SE, Lignot-Maleyran S, DeVries C, Sturkenboom M, Micon S, Hamoud F, et al. Administrative complexities for a European observational study despite directives harmonising requirements. Pharmacoepidemiol Drug Saf. 2012;21:851\u20136.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"953","key":"13_CR10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/pgmj.2004.026005","volume":"81","author":"JG O\u2019Grady","year":"2005","unstructured":"O\u2019Grady JG. Acute liver failure. Postgrad Med J. 2005;81(953):148\u201354.","journal-title":"Postgrad Med J"},{"issue":"2","key":"13_CR11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0016-5085(89)90081-4","volume":"97","author":"JG O\u2019Grady","year":"1989","unstructured":"O\u2019Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97(2):439\u201345.","journal-title":"Gastroenterology"},{"issue":"4","key":"13_CR12","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep.1840060417","volume":"6","author":"J Bernuau","year":"1986","unstructured":"Bernuau J, Goudeau A, Poynard T, Dubois F, Lesage G, Yvonnet B, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology. 1986;6(4):648\u201351.","journal-title":"Hepatology"},{"issue":"2","key":"13_CR13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","volume":"11","author":"C Benichou","year":"1990","unstructured":"Benichou C. Criteria of drug-induced liver disorders: report of an international consensus meeting. J Hepatol. 1990;11(2):272\u20136.","journal-title":"J Hepatol"},{"issue":"11","key":"13_CR14","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0895-4356(93)90102-7","volume":"46","author":"C Benichou","year":"1993","unstructured":"Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs: II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol. 1993;46(11):1331\u20136.","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"13_CR15","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","volume":"46","author":"G Danan","year":"1993","unstructured":"Danan G, Benichou C. Causality assessment of adverse reactions to drugs: I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol. 1993;46(11):1323\u201330.","journal-title":"J Clin Epidemiol"},{"issue":"8\u20139","key":"13_CR16","first-page":"581","volume":"11","author":"G Danan","year":"1987","unstructured":"Danan G, Benichou C, Begaud B, Biour M, Couzigou P, Evreux JC, et al. Criteria of imputation of acute hepatitis to a drug: results of consensus meetings [in French]. Gastroenterol Clin Biol. 1987;11(8\u20139):581\u20135.","journal-title":"Gastroenterol Clin Biol"},{"key":"13_CR17","unstructured":"Guidelines for ATC classification and DDD assignment. 4th ed. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2001."},{"issue":"5","key":"13_CR18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/pds.1951","volume":"19","author":"A Fourrier-Reglat","year":"2010","unstructured":"Fourrier-Reglat A, Cuong HM, Lassalle R, Depont F, Robinson P, Droz-Perroteau C, et al. Concordance between prescriber- and patient-reported previous medical history and NSAID indication in the CADEUS cohort. Pharmacoepidemiol Drug Saf. 2010;19(5):474\u201381.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"13_CR19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/clpt.2010.166","volume":"88","author":"A Fourrier-Reglat","year":"2010","unstructured":"Fourrier-Reglat A, Lacoin L, Pariente A, Lassalle R, Robinson P, Droz-Perroteau C, et al. When patients report diseases that prescribers seem unaware of: discordance between patient and physician reporting of risk-related previous history in NSAID users from the CADEUS study. Clin Pharmacol Ther. 2010;88(5):668\u201375.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"13_CR20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1067\/mcp.2001.116147","volume":"69","author":"N Moore","year":"2001","unstructured":"Moore N, Pierfitte C, Pehourcq F, Lagnaoui R, Begaud B. Comparison of patient questionnaires, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjects. Clin Pharmacol Ther. 2001;69(6):445\u201350.","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"13_CR21","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/pds.1388","volume":"16","author":"F Depont","year":"2007","unstructured":"Depont F, Fourrier A, Merliere Y, Droz C, Amouretti M, Begaud B, et al. Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study. Pharmacoepidemiol Drug Saf. 2007;16(8):891\u2013900.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"13_CR22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/pds.1348","volume":"16","author":"F Depont","year":"2007","unstructured":"Depont F, Fourrier A, Merliere Y, Droz C, Amouretti M, Begaud B, et al. The CADEUS study: methods and logistics. Pharmacoepidemiol Drug Saf. 2007;16(5):571\u201380.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"13_CR23","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1053\/j.gastro.2010.04.001","volume":"138","author":"N Chalasani","year":"2010","unstructured":"Chalasani N, Bjornsson E. Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology. 2010;138(7):2246\u201359.","journal-title":"Gastroenterology"},{"issue":"1","key":"13_CR24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11894-010-0154-8","volume":"13","author":"H Maddur","year":"2011","unstructured":"Maddur H, Chalasani N. Idiosyncratic drug-induced liver injury: a clinical update. Curr Gastroenterol Rep. 2011;13(1):65\u201371.","journal-title":"Curr Gastroenterol Rep"},{"key":"13_CR25","doi-asserted-by":"crossref","unstructured":"Aithal GP, Day CP. Nonsteroidal anti-inflammatory drug-induced hepatotoxicity. Clin Liver Dis. 2007;11(3):563\u201375, vi\u2013vii.","DOI":"10.1016\/j.cld.2007.06.004"},{"issue":"4","key":"13_CR26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0887-2333(95)00035-7","volume":"9","author":"X Ponsoda","year":"1995","unstructured":"Ponsoda X, Bort R, Jover R, Gomez-Lechon MJ, Castell JV. Molecular mechanism of diclofenac hepatotoxicity: association of cell injury with oxidative metabolism and decrease in ATP levels. Toxicol In Vitro. 1995;9(4):439\u201344.","journal-title":"Toxicol In Vitro"},{"key":"13_CR27","first-page":"w13080","volume":"140","author":"G Stirnimann","year":"2010","unstructured":"Stirnimann G, Kessebohm K, Lauterburg B. Liver injury caused by drugs: an update. Swiss Med Wkly. 2010;140:w13080.","journal-title":"Swiss Med Wkly"},{"issue":"2","key":"13_CR28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10787-010-0036-6","volume":"18","author":"GG Graham","year":"2010","unstructured":"Graham GG, Day RO, Graudins A, Mohamudally A. FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): are they reasonable? Inflammopharmacology. 2010;18(2):47\u201355.","journal-title":"Inflammopharmacology"},{"issue":"1","key":"13_CR29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.14219\/jada.archive.2011.0026","volume":"142","author":"J Guggenheimer","year":"2011","unstructured":"Guggenheimer J, Moore PA. The therapeutic applications of and risks associated with acetaminophen use: a review and update. J Am Dent Assoc. 2011;142(1):38\u201344.","journal-title":"J Am Dent Assoc"},{"key":"13_CR30","doi-asserted-by":"crossref","unstructured":"Craig DG, Bates CM, Davidson JS, Martin KG, Hayes PC, Simpson KJ. Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. Br J Clin Pharmacol. 2011.","DOI":"10.1111\/j.1365-2125.2010.03819.x"},{"key":"13_CR31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-230X-11-80","volume":"11","author":"M Sabate","year":"2011","unstructured":"Sabate M, Ibanez L, Perez E, Vidal X, Buti M, Xiol X, et al. Paracetamol in therapeutic dosages and acute liver injury: causality assessment in a prospective case series. BMC Gastroenterol. 2011;11:80.","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"13_CR32","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/hep.20948","volume":"42","author":"AM Larson","year":"2005","unstructured":"Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42(6):1364\u201372.","journal-title":"Hepatology"},{"issue":"6","key":"13_CR33","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0168-8278(98)80361-9","volume":"28","author":"RJ Andrade","year":"1998","unstructured":"Andrade RJ, Lucena MI, Garcia-Escano MD, Camargo R. Severe idiosyncratic acute hepatic injury caused by paracetamol. J Hepatol. 1998;28(6):1078.","journal-title":"J Hepatol"},{"issue":"2","key":"13_CR34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00045391-200007020-00011","volume":"7","author":"LF Prescott","year":"2000","unstructured":"Prescott LF. Paracetamol: past, present, and future. Am J Ther. 2000;7(2):143\u20137.","journal-title":"Am J Ther"},{"issue":"2","key":"13_CR35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00045391-200007020-00007","volume":"7","author":"LF Prescott","year":"2000","unstructured":"Prescott LF. Therapeutic misadventure with paracetamol: fact or fiction? Am J Ther. 2000;7(2):99\u2013114.","journal-title":"Am J Ther"},{"issue":"4","key":"13_CR36","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2125.2000.00167.x","volume":"49","author":"LF Prescott","year":"2000","unstructured":"Prescott LF. Paracetamol, alcohol and the liver. Br J Clin Pharmacol. 2000;49(4):291\u2013301.","journal-title":"Br J Clin Pharmacol"},{"key":"13_CR37","doi-asserted-by":"crossref","unstructured":"Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009;137(3):856\u201364, 864.e1.","DOI":"10.1053\/j.gastro.2009.06.006"},{"issue":"4","key":"13_CR38","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1345\/aph.1L528","volume":"43","author":"AM Weise","year":"2009","unstructured":"Weise AM, Liu CY, Shields AF. Fatal liver failure in a patient on acetaminophen treated with sunitinib malate and levothyroxine. Ann Pharmacother. 2009;43(4):761\u20136.","journal-title":"Ann Pharmacother"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-012-0013-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-012-0013-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-012-0013-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T19:45:09Z","timestamp":1714851909000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-012-0013-7"}},"subtitle":["The Multinational Case-Population SALT Study"],"short-title":[],"issued":{"date-parts":[[2013,1,17]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["13"],"URL":"https:\/\/doi.org\/10.1007\/s40264-012-0013-7","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,17]]}}}